Molecular Partners AG (MOLN) — Cash Flow Reinvestment Rate
Molecular Partners AG (MOLN) has a Cash Flow Reinvestment Rate of 0.57x as of March 2022, reinvesting CHF93.61 Million (capex CHF380.00K plus investments CHF-93.23 Million) from operating cash flow of CHF163.56 Million. Check MOLN cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Molecular Partners AG Cash Flow Reinvestment Rate (2015–2022)
Historical reinvestment intensity for Molecular Partners AG across 2 annual periods. Explore Molecular Partners AG (MOLN) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Molecular Partners AG (2015–2022)
Year-by-year capital reinvestment analysis for Molecular Partners AG. For live market cap and broader valuation context, see Molecular Partners AG (MOLN) total market value.
| Year | Reinvestment Rate | Total Reinvested (CHF) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.86x | CHF102.54 Million | CHF118.57 Million | CHF1.42 Million | ▲ +7.0% |
| 2015 | 0.81x | CHF21.41 Million | CHF26.50 Million | CHF1.39 Million | — |